@article{DieckmannPokrivcakGeczietal.2022,
  author    = {Klaus-Peter Dieckmann and Tomas Pokrivcak and Lajos Geczi and David Niehaus and Inken Dralle-Filiz and Cord Matthies and Tamas Dienes and Stefanie Zsch{\"a}bitz and Pia Paffenholz and Tanja Gschliesser and Renate Pichler and Michal Mego and Pia Bader and Friedemann Zengerling and Julia Heinzelbecker and Philipp Krausewitz and Susanne Krege and Gaetano Aurilio and Cem Aksoy and Marcus Hentrich and Christoph Seidel and P{\´e}ter T{\"o}rzs{\"o}k and Tim Nestler and Matthaeus Majewski and Andreas Hiester and Tomas Buchler and Sonia Vallet and Hana Studentova and Sandra Sch{\"o}nburg and Dora Nieders{\"u}ß-Beke and Julia Ring and Emanuela Trenti and Axel Heidenreich and Christian W{\"u}lfing and Hendrik Isbarn and Uwe Pichlmeier and Martin Pichler},
  title     = {Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study},
  journal   = {Therapeutic Advances in Medical Oncology},
  volume    = {14},
  pages     = {1 -- 13},
  doi       = {10.1177/17588359221086813},
  year      = {2022},
}